| Therapeutic use of omega-3 fatty acids in severe head trauma. | |
| | |
MedLine Citation:
|
PMID: 22867826 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Traumatic brain injury (TBI) has long been recognized as the leading cause of traumatic death and disability. Tremendous advances in surgical and intensive care unit management of the primary injury, including maintaining adequate oxygenation, controlling intracranial pressure, and ensuring proper cerebral perfusion pressure, have resulted in reduced mortality. However, the secondary injury phase of TBI is a prolonged pathogenic process characterized by neuroinflammation, excitatory amino acids, free radicals, and ion imbalance. There are no approved therapies to directly address these underlying processes. Here, we present a case that was intentionally treated with substantial amounts of omega-3 fatty acids (n-3FA) to provide the nutritional foundation for the brain to begin the healing process following severe TBI. Recent animal research supports the use of n-3FA, and clinical experience suggests that benefits may be possible from substantially and aggressively adding n-3FA to optimize the nutritional foundation of severe TBI patients and must be in place if the brain is to be given the opportunity to repair itself to the best possible extent. Administration early in the course of treatment, in the emergency department or sooner, has the potential to improve outcomes from this potentially devastating public health problem. |
| | |
Authors:
|
Michael Lewis; Parviz Ghassemi; Joseph Hibbeln |
Related Documents
:
|
15639096 - The transformation and toxicity of anthraquinone dyes during thermophilic (55 degrees c... 11931256 - Attractant volatiles released by female and male triatoma infestans (hemiptera: reduvii... 7612166 - Effect of type of lucerne hay on caecal fermentation and nitrogen contribution through ... 9366076 - Absorption and fate of l- and d-lactic acid in ruminants. 11097626 - Prostaglandins regulate acid-induced cell-mediated bone resorption. 1481976 - Resolution of dihydroxyeicosanoates and of dihydroxyeicosatrienoates by chiral phase ch... |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't Date: 2012-08-03 |
Journal Detail:
|
Title: The American journal of emergency medicine Volume: 31 ISSN: 1532-8171 ISO Abbreviation: Am J Emerg Med Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2012-12-10 Completed Date: 2013-03-14 Revised Date: 2013-04-02 |
Medline Journal Info:
|
Nlm Unique ID: 8309942 Medline TA: Am J Emerg Med Country: United States |
Other Details:
|
Languages: eng Pagination: 273.e5-8 Citation Subset: IM |
Copyright Information:
|
Copyright © 2013 Elsevier Inc. All rights reserved. |
Affiliation:
|
Brain Health Education and Research Foundation, Arlington, VA, USA. dr.michael.lewis@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Accidents, Traffic Adolescent Brain Injuries / diagnosis, drug therapy*, etiology, surgery Combined Modality Therapy Craniotomy Fatty Acids, Omega-3 / therapeutic use* Gastrostomy Humans Magnetic Resonance Imaging Male Tomography, X-Ray Computed Tracheotomy |
| Grant Support | |
ID/Acronym/Agency:
|
ZIA AA000115-12/AA/NIAAA NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Fatty Acids, Omega-3 |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia.
Next Document: Improving cardiac function with new-generation plasma volume expanders.